High-Quality Anti-Estrogen Letrozole Femara (CAS: 112809-51-5)

• Post Date:

  Jul 26,2017

• Expiry Date:

  Jan 22,2018

• Detailed Description:

  Cas No. :112809-51-5 Quantity: 500Kilograms
  Price:2000 USD Kilograms
  Letrozole Femara is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women.
  Letrozole Femara is intended for use only by women who are no longer of childbearing age. Possible candidates must have already ceased to menstruate. It is often used in patients who have already undergone other cancer treatments, such as radiation, chemotherapy, and used other cancer drugs, like tamoxifen. This nonsteroidal aromatase inhibitor may help prevent any remaining cancer cells from spreading.Email : anabolic@sinosteroids.com
  
  Website : www.sinosteroids.com
  
  Tel : +8617076116742
  

• CAS Registry Number:

  112809-51-5

• Synonyms:

  ;4,4'-(1h-1,2,4-Triazol-1-Ylmethylene)Bisbenzonitrile;Lelrozol;4,4'-(1h-1,2,4-Triazol-1-Ylmethylene) Bis-Benzonitrile;Femara;Letrozol;Letrazole;

• Molecular Formula:

  C₁₇H₁₁N₅

• Molecular Weight:

  285.31

• Molecular Structure:

  

• Company:

  HongKong Blue Universal Co., Limited.     [ China ]        

• Contact:

  Henry

• Tel:

  +86-170-76116742

• Fax:

  86-170-76116742

• Email:

  anabolic@sinosteroids.com